Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 31.83B | 32.12B | 33.75B | 29.88B | 22.55B | 20.94B |
Gross Profit | 10.46B | 13.96B | 14.65B | 5.20B | 4.25B | 3.96B |
EBITDA | 3.50B | 3.44B | 3.99B | 2.66B | 2.45B | 2.17B |
Net Income | 476.00M | 249.00M | 1.22B | 879.00M | 1.14B | 693.00M |
Balance Sheet | ||||||
Total Assets | 33.24B | 34.54B | 36.13B | 37.17B | 28.39B | 28.64B |
Cash, Cash Equivalents and Short-Term Investments | 1.34B | 2.19B | 2.36B | 2.53B | 2.23B | 2.83B |
Total Debt | 0.00 | 9.00B | 10.43B | 13.04B | 8.03B | 8.33B |
Total Liabilities | 19.41B | 19.78B | 21.68B | 23.39B | 15.06B | 17.36B |
Stockholders Equity | 11.53B | 12.27B | 12.31B | 12.29B | 11.94B | 9.37B |
Cash Flow | ||||||
Free Cash Flow | 3.03B | 3.16B | 4.04B | 1.03B | 1.03B | 2.54B |
Operating Cash Flow | 3.30B | 3.44B | 4.28B | 1.43B | 1.45B | 3.20B |
Investing Cash Flow | -1.59B | -1.86B | -542.00M | -4.26B | -258.00M | -694.00M |
Financing Cash Flow | -2.54B | -2.62B | -3.80B | 2.99B | -2.23B | -2.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | kr12.77B | 26.58 | 4.06% | 3.49% | -5.70% | -62.59% | |
65 Neutral | $10.81B | 15.65 | 5.50% | 1.89% | 3.10% | -27.09% | |
64 Neutral | kr5.83B | 13.31 | -3.12% | 3.05% | ― | ― | |
63 Neutral | kr4.03B | 102.16 | 7.13% | 0.28% | 2.42% | 20.90% | |
62 Neutral | €7.31B | 35.78 | 16.42% | ― | 10.18% | -1.08% | |
56 Neutral | kr21.49B | 185.23 | 0.27% | 0.95% | 13.61% | -97.82% | |
56 Neutral | €23.91B | ― | ― | -95.90% | 27.54% |
Ratos has appointed Markus Granlund as the permanent CEO of TFS HealthScience, a global Contract Research Organization (CRO) specializing in clinical development services across various therapeutic areas. Granlund’s leadership is expected to enhance TFS’s operational efficiency and strategic positioning in the global CRO market, benefiting stakeholders through improved client value and patient outcomes.
The most recent analyst rating on ($SE:RATO.B) stock is a Buy with a SEK45.00 price target. To see the full list of analyst forecasts on Ratos AB stock, see the SE:RATO.B Stock Forecast page.
Ratos AB is advancing its strategy to streamline operations by focusing on fewer business segments, particularly in infrastructure and industrial product solutions. This move includes the public listing of Sentia and the divestment of airteam, marking a significant step in reallocating resources towards segments with profitable growth and strong margins. The transactions are expected to improve Ratos’s EBITA margin by 200 basis points, although the leverage ratio will be negatively impacted due to a strong cash position. The company’s current stake in Sentia is valued at SEK 2.2 billion, and its divestment could further improve the leverage ratio significantly.
The most recent analyst rating on ($SE:RATO.B) stock is a Buy with a SEK45.00 price target. To see the full list of analyst forecasts on Ratos AB stock, see the SE:RATO.B Stock Forecast page.
Sentia ASA, a subsidiary of Ratos, successfully completed its bookbuilding process for its initial public offering (IPO), attracting significant interest and being nearly 15 times oversubscribed. The IPO is expected to raise substantial proceeds, with Sentia’s shares commencing trading on Euronext Oslo Børs on 13 June 2025. This milestone reduces Ratos’ ownership in Sentia and is seen as a testament to Sentia’s strength and potential as a leading Nordic construction group.
The most recent analyst rating on ($SE:RATO.B) stock is a Buy with a SEK45.00 price target. To see the full list of analyst forecasts on Ratos AB stock, see the SE:RATO.B Stock Forecast page.
Ratos AB announced the terms for Sentia’s initial public offering (IPO) on the Euronext Oslo Stock Exchange, with the prospectus approved by the Financial Supervisory Authority of Norway. The IPO consists of a secondary offering of up to 31,918,755 shares, with Ratos’ ownership in Sentia expected to reduce to approximately 39.8% post-IPO. This move is anticipated to enhance Sentia’s market presence and provide liquidity, potentially impacting Ratos’ strategic positioning in the construction sector.
The most recent analyst rating on ($SE:RATO.B) stock is a Buy with a SEK45.00 price target. To see the full list of analyst forecasts on Ratos AB stock, see the SE:RATO.B Stock Forecast page.
Sentia, a leading Nordic construction group, plans to apply for a listing on Euronext Oslo Børs, with Ratos holding a 72% stake prior to the listing. The listing aims to increase visibility, broaden ownership, and improve access to capital markets, aligning with Ratos’ strategy to streamline its holdings. Ratos intends to reduce its ownership to below 50% through a public offering and private placement, with cornerstone investors committing NOK 670 million.
The most recent analyst rating on ($SE:RATO.B) stock is a Buy with a SEK45.00 price target. To see the full list of analyst forecasts on Ratos AB stock, see the SE:RATO.B Stock Forecast page.
Ratos has announced changes to its management team, with Anna Vilogorac appointed as the new CFO, replacing the retiring Jonas Ågrup. Additionally, Wilhelm Montgomery has been promoted to Vice President of Strategy & Investments, reflecting Ratos’s increased focus on strategic execution and investments. These changes are part of Ratos’s ongoing transformation into a more streamlined and focused business group, aimed at enhancing value creation for stakeholders.
The most recent analyst rating on ($SE:RATO.B) stock is a Buy with a SEK45.00 price target. To see the full list of analyst forecasts on Ratos AB stock, see the SE:RATO.B Stock Forecast page.
Ratos AB has completed the divestment of airteam, a leading Nordic supplier of technical ventilation solutions, to Nalka Invest. This move aligns with Ratos’s strategy to streamline its operations towards a more uniform group with fewer platforms and strong margins, marking a significant step in its ongoing transformation.
The most recent analyst rating on ($SE:RATO.B) stock is a Buy with a SEK45.00 price target. To see the full list of analyst forecasts on Ratos AB stock, see the SE:RATO.B Stock Forecast page.